ChemicalBook > Product Catalog >Pharmaceutical intermediates >Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate

Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate

Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate Suppliers list
Company Name: Shanghai Rochi Pharmaceutical Co.,Ltd.
Tel: 21-38751876 +8615000076078
Email: info@rochipharma.com
Products Intro: Product Name:Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate
CAS:27143-07-3
Purity:99%min Package:1kg 5kg 10kg 25kg
Company Name: Hebei Chuanghai Biotechnology Co., Ltd
Tel: +8615350571055
Email: Sibel@chuanghaibio.com
Products Intro: Product Name:Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester
CAS:27143-07-3
Purity:99% Package:1KG;10.00;USD
Company Name: Shanghai Joiny Pharmaceutical Co.,LTD
Tel: +86-13681955282 +86-13681955282;
Email: gyd@joiny-pharma.com
Products Intro: Product Name:2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene]ethyl ester
CAS:27143-07-3
Purity:99% Package:25kg
Company Name: Henan Bao Enluo International TradeCo.,LTD
Tel: +86-17331933971
Email: deasea125996@gmail.com
Products Intro: Product Name:Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester
CAS:27143-07-3
Purity:99% Package:1kg;10USD
Company Name: Hangzhou ICH Biofarm Co., Ltd
Tel: +86-0571-28186870; +undefined8613073685410
Email: sales@ichemie.com
Products Intro: Product Name:Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester
CAS:27143-07-3
Purity:99% Package:1kg;|5kg;|10kg

Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate manufacturers

Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate Basic information
Product Name:Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate
Synonyms:2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene];ethyl 2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate;Apixaban Impurity B;(Z)-Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate (Apixaban);Apixaban-2;1-(4-methoxyphenyl)-4-(2-((4-(2-oxopiperidin-1-yl)phenyl)amino)ethyl)-1H-pyrazole-3,5-dicarboxamide;Chloro[(4-methoxyphenyl)hydrazono]acetic acid ethyl ester;(Z)- Ethyl chloro[(4-Methoxyphenyl)hydrazono]acetate
CAS:27143-07-3
MF:C11H13ClN2O3
MW:256.69
EINECS:608-053-7
Product Categories:27143-07-3
Mol File:27143-07-3.mol
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate Structure
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate Chemical Properties
Melting point 94℃
Boiling point 349.0±44.0 °C(Predicted)
density 1.23
storage temp. 2-8°C
solubility Chloroform (Sparingly), Methanol (Slightly)
form Solid
pka11.63±0.10(Predicted)
color Yellow to Dark Yellow
InChIInChI=1S/C11H13ClN2O3/c1-3-17-11(15)10(12)14-13-8-4-6-9(16-2)7-5-8/h4-7,13H,3H2,1-2H3
InChIKeyATNPZEGMKLGIFA-UHFFFAOYSA-N
SMILESC(OCC)(=O)C(Cl)=NNC1=CC=C(OC)C=C1
Safety Information
MSDS Information
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate Usage And Synthesis
Physical propertiesLight yellow to dark yellow solid
UsesAcetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester is an ester derivative and can be used as an intermediate in the synthesis of apixaban.
SynthesisStep-1:Water (600 ml) was added to p-anisidine (100 g) at room temperature and the resulting mixture was cooled to 10°C, followed by the addition of concentrated hydrochloric acid (133.5 g). The resulting mixture was cooled to —5°C to 0°C, followed by portion-wise addition of 40 % aqueous sodium nitrite solution over 45 minutes to 1 hour. The resulting mass was stirred for 1 hour 30 minutes at —5°C to0°C, followed by slow addition of 11 % sulfamic acid solution over 1 hour to 1 hour 30 minutes to produce a reaction mass (first part).Step-2:Sodium acetate (146 g) was added to water (300 ml) at room temperature and then stirred for 10 minutes to 15 minutes, followed by the addition of ethyl 2-chloroacetoacetate (160.4g) and acetone (300 ml) at room temperature to form a reaction mixture. The resulting mixture was cooled to 0°C. The resulting mixture was added to the reaction mass (first part) obtained in step-i at —5°C to 0°C and then stirred for 1 hour at the same temperature. Acetone (200 ml) was added to the resulting mass and stirred for 30 minutes at —5°C to 0°C. The resulting mass was settled for 5 hours at —5°C to 0°Cand then filtered the solid. Methanol (150 ml) was added to the resulting solid at room temperature and then stirred for 2 hours at the same temperature. Ethyl 2-chloro-2-(2-(4-methoxyphenyl) hydrazone)acetate was obtained through further purity.
References[1] Patent: CN104513239, 2017, B. Location in patent: Paragraph 0197; 0238; 0243; 0244
[2] European Journal of Medicinal Chemistry, 2016, vol. 123, p. 431 - 446
[3] Patent: CN107400131, 2017, A. Location in patent: Paragraph 0026; 0031; 0042-0044
[4] Patent: CN105384739, 2016, A. Location in patent: Paragraph 0391; 0392; 0393
[5] Patent: CN104395312, 2016, B. Location in patent: Paragraph 0396; 0451-0455; 0501; 0502-0506
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate Preparation Products And Raw materials
Raw materialsp-Anisidine-->Ethyl 4-chloroacetoacetate-->Ethyl 2-chloroacetoacetate-->Sodium acetate-->Hydrochloric acid-->Sodium nitrite
Tag:Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate(27143-07-3) Related Product Information
Apixaban Impurity 20 (4,4'‐didodecyl‐2,2'‐ bithiophene‐5,5'‐ diyl)bis(triMethylstann ane) 1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide Apixaban Impurity 13 ETHYL (2E)-CHLORO[(4-CHLOROPHENYL)HYDRAZONO]ACETATE 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid Apixaban IMpurity 3 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide Apixaban Impurity 11 Apixaban IMpurity 5 (BMS-591329-01) 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester 1-(4-Nitrophenyl)-2-piperidinone 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HCl (R)-3-Piperidinamine dihydrochloride